share_log

南京证券股份有限公司关于江苏诺泰澳赛诺生物制药股份有限公司使用部分募集资金向全资子公司增资用于实施募投项目的核查意见

Opinion on verification of Jiangsu Notai Ausanuo Biopharmaceutical Co., Ltd.'s use of part of the raised funds to increase capital to fully-owned subsidiaries for the implementation of the raised investment project by Nanjing Securities Co., Ltd.

Sensex a share ·  Jun 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more